Factors affecting target INR levels in homebound and ambulatory patients who use warfarin

Factors affecting target INR levels in homebound and ambulatory patients who use warfarin

Objective: To investigate the rates of reaching target international normalised ratio levels and the factors affecting these rates in patients undergoing warfarin therapy. Method: The prospective cross-sectional study was conducted between 16.08.2023 and 16.11.2023 at Izmir Bozyaka Training and R...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ozge Tuncer, Ayca Asma Sakalli, Mustafa Ozan Gursoy
Format:	Article
Language:	English
Published:	Pakistan Medical Association 2024-11-01
Series:	Journal of the Pakistan Medical Association
Subjects:	Warfarin therapy Anticoagulants Patients’ education
Online Access:	https://jpma.org.pk/index.php/public_html/article/view/11373
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimum INR intensity and therapeutic INR control in patients with mechanical heart valve prosthesis on warfarin oral anticoagulation at Dr George Mukhari academic hospital: a three-year retrospective study
by: S. Ntlokotsi, et al.
Published: (2018-11-01)

Study of target INR achievement, incidence of hemorrhagic complications and affecting factors after during warfarin treatment in western area of China
by: Rui Shi, et al.
Published: (2025-05-01)

SYNTHESIS, PHYSICO-CHEMICAL ANALYSIS AND PHARMACOLOGICAL ACTIVITY OF SOME DERIVATIVES OF WARFARIN
by: A. Z. Abyshev, et al.
Published: (2019-01-01)

Nontraumatic warfarin-related intrapulmonary hemorrhage presenting as a lung mass
by: Hiroyuki Tsuchida, et al.
Published: (2020-04-01)

SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS
by: E. S. Kropacheva
Published: (2016-01-01)

Severe Airway Obstruction due to Massive Retropharyngeal Hematoma in a Warfarin-Taking Patient with a Normal International Normalized Ratio
by: Hyun Young Cho, et al.
Published: (2021-03-01)

Appropriate target range of INR and predictive factors of recurrent thrombosis and bleeding in patients with venous thromboembolism on warfarin
by: Peerasit Sae-Lim, et al.
Published: (2025-07-01)

CYP2C9*2 and CYP2C9*3 allele variants of CYP2C9 cytochrome gene in St. Petersburg population, and their clinical role in warfarin anticoagulant therapy
by: O. V. Sirotkina, et al.
Published: (2004-12-01)

Factors influencing nurses’ knowledge and competence in warfarin-drug and nutrient interactions and patient counseling practices
by: Maha Subih, et al.
Published: (2025-04-01)

Determining the effect of drug "Warfarin sodium" on toxicity indicators in an acute experiment
by: D.O. Hlavachek, et al.
Published: (2023-09-01)

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
by: N. T. Vatutin, et al.
Published: (2020-03-01)

WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT
by: S. Yu. Martsevich, et al.
Published: (2017-11-01)

An unusual complication during anticoagulant therapy
by: M. T. Vatutin, et al.
Published: (2015-10-01)

Frequencies of polymorphisms in genes affecting the pharmacokinetics of warfarin in the Zaporizhzhia region
by: M. Yu. Kolesnik, et al.
Published: (2021-07-01)

Using the software «DAWN AC» for control of dosing warfarin in the special anticoagulation clinics
by: O. S. Napalkova, et al.
Published: (2015-06-01)

Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study
by: Firafan Shuma Teka, et al.
Published: (2025-04-01)

Temporal Changes in Long‐Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era
by: Kazuhisa Kaneda, et al.
Published: (2024-08-01)

Association between knowledge of anticoagulation, INR control, and warfarin-related adverse events: a cross sectional study
by: Noor Kokash, et al.
Published: (2025-03-01)

Quality of Anticoagulation Management with Warfarin among Patients in Orotta National Referral Hospital, Asmara, Eritrea: A Retrospective Cross-Sectional Study
by: Natnael Russom, et al.
Published: (2022-10-01)

Assessment of Knowledge and Training Needs for the Clinical Management of Warfarin Anticoagulation Among Physicians in China
by: Luo A, et al.
Published: (2025-02-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

Risk of development of hemorrhagic complications due to warfarin therapy
by: O. I. Filippova, et al.
Published: (2017-12-01)

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2015-09-01)

Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran
by: N. A. Novikova, et al.
Published: (2021-05-01)

WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE
by: E. N. Dankovtseva, et al.
Published: (2015-12-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

POTENTIAL OF PHARMACOGENETICS IN THE CORRECTION OF ANTICOAGULANT THERAPY AMONG PATIENT WITH PROSTHETIC HEART VALVES
by: I. Yu. Zhuravleva, et al.
Published: (2013-06-01)

GENETIC FACTORS INFLUENCING THE EFFECTIVENESS AND SAFETY OF LONG-TERM ANTICOAGULANT THERAPY
by: T. V. Burkova, et al.
Published: (2013-06-01)

Clinical Case: Atypical Warfarin-induced Skin Necrosis
by: T. V. Kondratieva, et al.
Published: (2019-11-01)

Anticoagulation knowledge assessment in unprivileged people of Baluchistan
by: Khuzaima Tariq, et al.
Published: (2024-11-01)

Risk of postoperative bleeding following dental extractions in patients on antithrombotic treatment
by: Mohammed AlSheef, et al.
Published: (2021-11-01)

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
by: Emilie Clay, et al.
Published: (2018-01-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

The impact of anti-infective therapy on patients undergoing warfarin treatment
by: Linlin Fu, et al.
Published: (2024-12-01)

Warfarin without Therapeutic Monitoring Is a Rodenticide, but This Time It Kills the Patient: A Warfarin Toxicity Case Report
by: Hossein Karballaei Mirzahosseini, et al.
Published: (2024-11-01)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016-01-01)

Diagnosis of Impairments in the Hemostatic System in the Use of Warfarin in Cardiac Surgical Patients
by: E. I. Goncharova, et al.
Published: (2015-09-01)

Efficacy and safety of off-label direct oral anticoagulants vs. warfarin for left ventricular thrombus: an inverse probability of treatment weighting analysis
by: Taha Al-Maimoony, et al.
Published: (2025-04-01)

Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic
by: S. M. Mamatov, et al.
Published: (2021-05-01)